Suppr超能文献

小胶质细胞在多发性硬化症发病机制中的作用:协同还是拮抗?

Role of Microglial Cells in the Pathophysiology of MS: Synergistic or Antagonistic?

机构信息

Department of Neurology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, 40-055 Katowice, Poland.

Department of Otorhinolaryngology and Oncological Laryngology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, 40-055 Katowice, Poland.

出版信息

Int J Mol Sci. 2023 Jan 17;24(3):1861. doi: 10.3390/ijms24031861.

Abstract

Many studies indicate an important role of microglia and their cytokines in the pathophysiology of multiple sclerosis (MS). Microglia are the macrophages of the central nervous system (CNS). They have many functions, such as being "controllers" of the CNS homeostasis in pathological and healthy conditions, playing a key role in the active immune defense of the CNS. Macroglia exhibit a dual role, depending on the phenotype they adopt. First, they can exhibit neurotoxic effects, which are harmful in the case of MS. However, they also show neuroprotective and regenerative effects in this disease. Many of the effects of microglia are mediated through the cytokines they secrete, which have either positive or negative properties. Neurotoxic and pro-inflammatory effects can be mediated by microglia via lipopolysaccharide and gamma interferon. On the other hand, the mediators of anti-inflammatory and protective effects secreted by microglia can be, for example, interleukin-4 and -13. Further investigation into the role of microglia in MS pathophysiology may perhaps lead to the discovery of new therapies for MS, as recent research in this area has been very promising.

摘要

许多研究表明小胶质细胞及其细胞因子在多发性硬化症(MS)的病理生理学中起着重要作用。小胶质细胞是中枢神经系统(CNS)的巨噬细胞。它们具有许多功能,例如在病理和生理条件下作为 CNS 内稳态的“控制器”,在 CNS 的主动免疫防御中发挥关键作用。巨胶质细胞表现出双重作用,具体取决于它们所采用的表型。首先,它们可以表现出神经毒性作用,在 MS 的情况下是有害的。然而,它们在这种疾病中也表现出神经保护和再生作用。小胶质细胞的许多作用是通过它们分泌的细胞因子介导的,这些细胞因子具有正或负的特性。通过脂多糖和γ干扰素,小胶质细胞可以介导神经毒性和促炎作用。另一方面,小胶质细胞分泌的抗炎和保护作用的介质可以是白细胞介素-4 和白细胞介素-13。对小胶质细胞在 MS 病理生理学中的作用的进一步研究可能会发现针对 MS 的新疗法,因为该领域的最新研究非常有前景。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d35/9916250/200353cfffef/ijms-24-01861-g001.jpg

相似文献

1
Role of Microglial Cells in the Pathophysiology of MS: Synergistic or Antagonistic?
Int J Mol Sci. 2023 Jan 17;24(3):1861. doi: 10.3390/ijms24031861.
2
Neuronal injury in chronic CNS inflammation.
Best Pract Res Clin Anaesthesiol. 2010 Dec;24(4):551-62. doi: 10.1016/j.bpa.2010.11.001. Epub 2010 Nov 29.
3
CSF1R signaling is a regulator of pathogenesis in progressive MS.
Cell Death Dis. 2020 Oct 23;11(10):904. doi: 10.1038/s41419-020-03084-7.
4
Fibronectin aggregates promote features of a classically and alternatively activated phenotype in macrophages.
J Neuroinflammation. 2018 Aug 2;15(1):218. doi: 10.1186/s12974-018-1238-x.
5
Identification of new therapeutic targets for prevention of CNS inflammation.
Expert Opin Ther Targets. 2002 Apr;6(2):203-15. doi: 10.1517/14728222.6.2.203.
6
The roles of macrophages and microglia in multiple sclerosis and experimental autoimmune encephalomyelitis.
J Neuroimmunol. 2018 May 15;318:1-7. doi: 10.1016/j.jneuroim.2018.02.015. Epub 2018 Feb 27.
10
Preactive multiple sclerosis lesions offer novel clues for neuroprotective therapeutic strategies.
CNS Neurol Disord Drug Targets. 2011 Feb;10(1):68-81. doi: 10.2174/187152711794488566.

引用本文的文献

1
Neurotrophic factors in multiple sclerosis.
Front Immunol. 2025 Aug 27;16:1654603. doi: 10.3389/fimmu.2025.1654603. eCollection 2025.
2
Therapeutics Potential of Cronassial in Experimental Autoimmune Encephalomyelitis: Insights Into Glycosphingolipids and Humoral Immunity.
ScientificWorldJournal. 2025 Jul 18;2025:9108462. doi: 10.1155/tswj/9108462. eCollection 2025.
3
Dementia in People With Multiple Sclerosis: A Systematic Review and Meta-Analysis.
Brain Behav. 2025 Jun;15(6):e70588. doi: 10.1002/brb3.70588.
6
Novel Cell Models to Study Myelin and Microglia Interactions.
Int J Mol Sci. 2025 Feb 28;26(5):2179. doi: 10.3390/ijms26052179.
8
Glial Cells as Key Regulators in Neuroinflammatory Mechanisms Associated with Multiple Sclerosis.
Int J Mol Sci. 2024 Sep 4;25(17):9588. doi: 10.3390/ijms25179588.
10
Smouldering Lesion in MS: Microglia, Lymphocytes and Pathobiochemical Mechanisms.
Int J Mol Sci. 2023 Aug 10;24(16):12631. doi: 10.3390/ijms241612631.

本文引用的文献

1
Bruton's Tyrosine Kinase Inhibition in Multiple Sclerosis.
Curr Neurol Neurosci Rep. 2022 Nov;22(11):721-734. doi: 10.1007/s11910-022-01229-z. Epub 2022 Oct 27.
2
Microglia in multiple sclerosis: Protectors turn destroyers.
Neuron. 2022 Nov 2;110(21):3534-3548. doi: 10.1016/j.neuron.2022.06.023. Epub 2022 Jul 25.
3
Microglia Phenotypes in Aging and Neurodegenerative Diseases.
Cells. 2022 Jun 30;11(13):2091. doi: 10.3390/cells11132091.
4
Microglia Polarization From M1 to M2 in Neurodegenerative Diseases.
Front Aging Neurosci. 2022 Feb 16;14:815347. doi: 10.3389/fnagi.2022.815347. eCollection 2022.
8
A lymphocyte-microglia-astrocyte axis in chronic active multiple sclerosis.
Nature. 2021 Sep;597(7878):709-714. doi: 10.1038/s41586-021-03892-7. Epub 2021 Sep 8.
10
Bruton's Tyrosine Kinase Inhibition in the Treatment of Preclinical Models and Multiple Sclerosis.
Curr Pharm Des. 2022;28(6):437-444. doi: 10.2174/1381612827666210701152934.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验